chrisvoncsefalvay/vaers-outcomes huggingface dataset:
itching in the upper chest, breasts, armpits; Nausea; headache; Body aches; Chills; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old patient of unspecified gender received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 10Mar2021 at 12:00 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety, panic disorder and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included sertraline hydrochloride (ZOLOFT) for an unknown indication from an unknown date, unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM9810) via an unspecified route of administration in the right arm on 17Feb2021 at 12:00 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. On 11Mar2021 at 02:00, the patient experienced itching in the upper chest, breasts, armpits, nausea, headache, body aches and chills. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events itching in the upper chest, breasts, armpits, nausea, headache, body aches and chills was recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Vaccination side was swollen this morning; Seemed to be experiencing fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Vaccination side was swollen this morning) and FATIGUE (Seemed to be experiencing fatigue) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 042120A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension, Diabetes mellitus and Arthritis.   On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Mar-2021, the patient experienced VACCINATION SITE SWELLING (Vaccination side was swollen this morning) and FATIGUE (Seemed to be experiencing fatigue). At the time of the report, VACCINATION SITE SWELLING (Vaccination side was swollen this morning) and FATIGUE (Seemed to be experiencing fatigue) had resolved.
I had a dr appointment 2 hrs after the 1st dose of Pfizer, my blood pressure was 195/95. It is usually 155/85. It stayed high for a couple weeks. I took extra potassium and cut out all caffeine to help bring it down. It happened again with the 2nd dose on 4/22/21. Taken at my Urologist
A report was received from a health care professional on 11/08/03, concerning an 88 year old female vaccinee who inadvertently received a second dose of Fluvirin on 11/07/03. On 11/04/03, an 88 year old female vaccinee was administered 0.5mls Fluvirin. Subsequently on 11/7/03, the vaccinee received a further dose of 0.5mls of Fluvirin. The vaccinee did not exhibit any untoward sings or symptoms at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Update 1, 02/16/04: A follow up report was received from a health care professional indicating that there was no adverse events experienced by the vaccinee. No follow up pending, all information received.
Patient is experiencing consistent pain in left arm. She has difficulty moving her arm and limited range of motion.
Brain was not functioning well; Had burning sensation in the legs; Has no energy; Fatigue; Fever; so sick for 9 weeks that I almost died; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (so sick for 9 weeks that I almost died), DISTURBANCE IN ATTENTION (Brain was not functioning well), BURNING SENSATION (Had burning sensation in the legs), ASTHENIA (Has no energy) and FATIGUE (Fatigue) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030B21 and 003B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Apr-2021, the patient experienced DISTURBANCE IN ATTENTION (Brain was not functioning well), BURNING SENSATION (Had burning sensation in the legs), ASTHENIA (Has no energy) and FATIGUE (Fatigue). 15-Apr-2021, the patient experienced PYREXIA (Fever). On an unknown date, the patient experienced MALAISE (so sick for 9 weeks that I almost died). At the time of the report, MALAISE (so sick for 9 weeks that I almost died) had resolved and DISTURBANCE IN ATTENTION (Brain was not functioning well), BURNING SENSATION (Had burning sensation in the legs), ASTHENIA (Has no energy), FATIGUE (Fatigue) and PYREXIA (Fever) outcome was unknown.            No concomitant medication was reported.  On 15-APR-2021, the patient felt that she couldn't do anything. Treatment medication was not provided.  Company comment: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.   This case was linked to MOD-2021-106941 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Event added.; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.
Patient described as a knot on arm and became bruised, contacted her doctor who said it was an adverse reaction, has doctor appointment today 11/19/12.
itchiness, redness/inflammation, heat over the course of ~3 -4days. Day 1 - itchiness and mild redness at the site of injection. Day 2 - itchiness and bright redness/inflammation/heat (~3 inch diameter circle) at the site of injection. Very mild pain when pressed. Day 3 - Redness still visible but fading and less heat. Day 4 - Redness mostly faded. Day 5 - normal
Severe dizziness, nausea, vomiting, body aches. My symptoms lasted for a week, and two weeks later I developed a burning sensation in my mouth along with my lips, throat and tongue. I have not completely recovered from the fatigue and burning sensations in my mouth over a month later.
Burning red welt as big as my hand at vaccination site. Lasted three days then swelling went down and was itchy for one day.
Patient was given a pediatric dose of Hep A and Hep B. Patient needs an adult dose will have to have one more dose of each vaccine.
3/25/21 @1pm - Two 1/2" red, itchy, swollen lumps a few inches down from injection site on my left arm.  3/26/21 @8:30am - One red, swollen, hard 3"-4" rash (looked like a welt) in the same site as the swollen lumps from yesterday.  Felt hot and tender to the touch.  Swollen left underarm gland.  Menstrual spotting.  3/27/21 @10pm - Area of the rash is just pink...like it's fading.  No swelling.  Menstrual spotting stopped.  3/28/21 @9am - Rash is gone.
SHOT REALLY HURT PATIENT SAID SHE GOT BURSITIS WHERE THE VACCINE WAS INJECTED PATIENT CLAIMS THE VACCINE WAS  ADMINISTERED TO HIGH ON HER RIGHT ARM ( EXTRAORDINARY PAIN)
Initial case received from a nurse on 17 November 2010. This involves a case of misuse, i.e. wrong vaccine administered; it is also a pregnancy case. The patient is 1 of a cluster of 5 patients who experienced adverse events following intradermal administration of DECAVAC. A 32-year-old pregnant female patient received a left forearm intradermal injection of DECAVAC (lot number U3422DA) instead of TUBERSOL 5TU on 16 November 2010. The patient was 11 weeks pregnant at the time of vaccination, and medical history included CIPRO allergy. She had a history of 2 previous miscarriages. Following vaccination, the patient developed a 6 cm x 7 cm area around the vaccination site which was red, hot, and raised. She also complained of a 6 cm x 7 cm lighter red streak going up the arm towards the elbow, and noted that her left 5th finger "feels like it wants to contract". She was not taking any medications, and was not ill at the time of vaccination. The event was ongoing at the time of the report. The events for the other patients in this cluster are captured in case numbers 2010-06503, 2010-03604, and 2010-03608.
Ringing in ears  Sore lymph nodes  Main soreness on left leg and hand on left side (only one sided pain)?  Neck pain and chest soreness  Fatigue/tiredness
Patient experienced extreme pain (8 of 10) starting approximately 6 hours after administration of the vaccine. She also developed severe body aches, headache, nausea, and body chills. She tried to control symptoms with home remedies such as taking a bath, using a hot pad and blankets to help with the chills but they did not help. She thought about going into the hospital but decided against it. She felt bad for about a day and a half and started to feel slightly better by 11pm of Sunday night. Monday she was almost fully recovered. She said that she reacted more severely with the second dose but it was a shorter duration than the first dose.
Developed injection site pain; no lump or discoloration. MD visit inconclusive. Advised warm, wet compresses.
Within 5 hours of receiving the vaccine, my arm/shoulder were extremely painful and I had limited range of motion. The next morning it was worse. I looked at the site and realized the shot had been administered at site top of my arm - nearly on top of my shoulder. Improvement has been gradual. PCP, Ortho, PT, ?Bone ?Bursal sac ?Tendon.
Swollen top and bottom lips, triage, IV & Benadryl for allergy. Took 5 days (antibiotic and Benadryl
Per phone conversation with mother symptoms started 9-11-13 at 2:30-3:00 PM. Over the next 24 hours her daughter had projectile vomiting, shaking, sweating, chills. "Tylenol didn't seem to help." Mother states she was unable to take temp. due to vomiting and nausea. With first phone call on 9-12-13 it was recommended that mother take child to PCP for evaluation. Mother also stated child had a baseball size swelling on her right arm. Fol. up call on 9-13-13 found that mother considered child fully recovered with arm swelling gone. She had not taken child to MD. She stated she had called them and was told not to bring her in as "there was nothing they could do".
I had itching on my arm with a welt that was 2x3 and swollen. Within about 24 hrs,  I had two more welts that came up on my arm.  I had a consult with my doctor. There was concern it was cellulitus.  But it was not cellulitus. They wanted to start me on antibiotics but I waited and just took benadryl.
Muscle pain all over her body from head to toe started the day after inoculation. She states it was horrible pain; This is a spontaneous report received from a contactable reporter(s) (Other HCP).  A 84 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administration date 31Mar2022 (Lot number: FL3209) at the age of 84 years as dose 4 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Vaccine brand: Pfizer / BioNTech, Vaccine brand unknown: False, Vaccine administration date: 28Sep2021, Vaccine lot number: FF2557, Vaccine lot unknown: False, Vaccine dose number: 3, Vaccine dose number unknown: False, Vaccine location: Left arm), administration date: 28Sep2021, when the patient was 83 years old, for Covid-19 immunization; Bnt162b2 (Vaccine brand: Pfizer / BioNTech, Vaccine brand unknown: False, Vaccine administration date: 27Feb2021, Vaccine administration time: 09:45 AM, Vaccine lot number: EN6198, Vaccine lot unknown: False, Vaccine dose number: 2, Vaccine dose number unknown: False, Vaccine location: Left arm), administration date: 27Feb2021, when the patient was 83 years old, for Covid-19 immunization; Bnt162b2 (Vaccine brand: Pfizer / BioNTech, Vaccine brand unknown: False, Vaccine administration date: 06Feb2021, Vaccine administration time: 02:15 PM, Vaccine lot number: EM9180, Vaccine lot unknown: False, Vaccine dose number: 1, Vaccine dose number unknown: False, Vaccine location: Left arm), administration date: 06Feb2021, when the patient was 83 years old, for Covid-19 immunization.  The following information was reported: MYALGIA (non-serious) with onset 02Apr2022, outcome "recovering", described as "Muscle pain all over her body from head to toe started the day after inoculation. She states it was horrible pain". Therapeutic measures were not taken as a result of myalgia.  Additional Information: Adverse event: Muscle pain all over her body from head to toe started the day after inoculation. She states it was horrible pain. Today 05Apr2022 she is feeling a bit better.  No follow-up attempts are possible. No further information is expected.
Pt states that 3 days, post vax, she got Bell's Palsy.
Some of the vaccine (approximately 0.1ml ) leaked out; Needle tip came loss from the syringe; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of UNDERDOSE (Some of the vaccine (approximately 0.1ml ) leaked out) and DEVICE CONNECTION ISSUE (Needle tip came loss from the syringe) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Mar-2021 at 2:33 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced UNDERDOSE (Some of the vaccine (approximately 0.1ml ) leaked out) and DEVICE CONNECTION ISSUE (Needle tip came loss from the syringe). On 16-Mar-2021, UNDERDOSE (Some of the vaccine (approximately 0.1ml ) leaked out) and DEVICE CONNECTION ISSUE (Needle tip came loss from the syringe) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment details were not provided  It was reported that the Patient received more than Half of the vaccine.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: Follow-up information received on 22-JUN-2021. Time of the 2nd dose administered was Updated and Fax number also updated.
Diarrhea, nausea with dry heaves which resulted in light headedness.  Resolved with fluids and rest later on in the day.
I'm having a lot of dizziness and Lightheadedness/I had to go to urgent care for dizziness; Extreme hot flashes which I didn't even have during menopause/I am experiencing extreme hot flashes that i never felt before; I got a rash over my torso neck and chest; I cant go on long walks, having brain fog; having brain fog/ I do not usually feel this way; second vaccine gave covid arm lasting 2 weeks; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (I'm having a lot of dizziness and Lightheadedness/I had to go to urgent care for dizziness), HOT FLUSH (Extreme hot flashes which I didn't even have during menopause/I am experiencing extreme hot flashes that i never felt before), RASH (I got a rash over my torso neck and chest), GAIT DISTURBANCE (I cant go on long walks, having brain fog) and FEELING ABNORMAL (having brain fog/ I do not usually feel this way) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LEVOTHYROXINE for an unknown indication.    On 26-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (I'm having a lot of dizziness and Lightheadedness/I had to go to urgent care for dizziness), HOT FLUSH (Extreme hot flashes which I didn't even have during menopause/I am experiencing extreme hot flashes that i never felt before), RASH (I got a rash over my torso neck and chest), GAIT DISTURBANCE (I cant go on long walks, having brain fog), FEELING ABNORMAL (having brain fog/ I do not usually feel this way) and VACCINATION SITE REACTION (second vaccine gave covid arm lasting 2 weeks). At the time of the report, DIZZINESS (I'm having a lot of dizziness and Lightheadedness/I had to go to urgent care for dizziness), HOT FLUSH (Extreme hot flashes which I didn't even have during menopause/I am experiencing extreme hot flashes that i never felt before), RASH (I got a rash over my torso neck and chest), GAIT DISTURBANCE (I cant go on long walks, having brain fog), FEELING ABNORMAL (having brain fog/ I do not usually feel this way) and VACCINATION SITE REACTION (second vaccine gave covid arm lasting 2 weeks) outcome was unknown.            Treatment information was not provided.   This case was linked to MOD-2021-311001 (Patient Link).
Information has been received from a physician concerning a 14 year old female who on an unspecified date was vaccinated with a dose of GARDASIL (dose, route, and lot# not reported). On an unspecified date the patient experienced tachycardia while going through the GARDASIL series and was hospitalized. The patient's tachycardia persisted. Tachycardia was considered to be disabling by the reporter. Additional information has been requested.
after the second vaccine I had 22 days of fatigue.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID. The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2, bnt162b2 omi ba.4-5 (Dose 1, Single. I got the first vaccine and had one week of fatigue), for COVID-19 immunization, reaction(s): "fatigue". The following information was reported: FATIGUE (non-serious), outcome "not recovered", described as "after the second vaccine I had 22 days of fatigue.". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: I'm reaching out to you to find out if fatigue is one of the side effects of the Pfizer vaccine. After the second vaccine I had 22 days of fatigue. It is continued sporadically almost every month with fatigue that last from 2 to 5 days. If it is from the vaccine what actions can I take to deal with this situation. Please reply since my internist doesn't know why I'm getting this fatigue blood work shows no indications. case was reported as non-serious.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
fever 102, rt leg not swollen & hard, cry high pitch times 2 hrs; called MD; inc APAP & recommended omitting pertussis vax
Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in an 87-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 02-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication reported.  No treatment medication reported.    This case was linked to MOD-2021-332638 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Follow-up contains non-significant information.
1 day after my 2nd dose, I experienced body aches (specifically the part of my arm which I got injected), Fatigue, I took 2 tabs of Tylenol and did a bed rest for the rest of the day and it went all through out the next day then the 3rd day I was back to feeling normal again.
Information has been received from an office staff member on behalf of a physician concerning an 11 year old white male who on 05JUN1995 was vaccinated with a first dose of varicella virus vaccine live. On 14NOV2003 the patient developed clinical varicella. Unspecified medical attention was sought. No diagnostic tests were performed. Subsequently, the patient recovered. No product quality complaint was involved. It was also reported that another patient was vaccinated with a dose of varicella virus vaccine live and developed chicken pox. No further information is expected.
Tonic Clonic Seizure acttivity lasting 2 minutes.  6/29/09 Hospital records received DOS 5/19/09 to 5/21/09. Assessment: Acute onset seizure secondary to vaccination.  Patient presented with body shaking, eyes rolled up, struggling to breath, stopped breathing. Crying, fussy.  7/21/09 ICD-9 Codes: 780.39
About 5-7 PM that evening started to feel cold/chills. That night felt like worse day of my life, chills, bad body pains/ache and sweaty hot, next day like bad flu, second night not as bad, 2nd day better. After about 48 hrs back to normal. Also on 2nd day a cyst formed on my right front neck by throat, fever.
Information has been received from a certified medical assistant (CMA) referring to an unknown number of patients of unknown age and gender. No relevant medical history or concurrent conditions were reported. The reporting medical assistant reported that, since 02-JUL-2015, these patients were vaccinated with VAQTA (lot # L009445, expiration date 01-JUN-2017; lot # K019560, 02-JUN-2017; lot # L007559, expiration date 01-JUN-2017; dose and route not reported) which were exposed to temperatures outside of the recommended range on 02-JUL-2015. Among them, unspecified patients received VAQTA (lot # L007559, expiration date 01-JUN-2017) on 07-AUG-2015 (reported as 07-AUG-2016), 11-AUG-2015, 12-AUG-2015 and 13-AUG-2015. No adverse experience was reported. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report as received from a consumer refers to a 63 year old male patient with high blood pressure and with no drug reactions or allergies. On 31-AUG-2015 the patient was vaccinated with a dose of ZOSTAVAX (dose, route and lot number were not reported. Concomitant therapies included LOTREL. On 01-SEP-2015, the patient experienced injection site swelling. He also reported that within two more days (in September 2015), he had been experiencing a burning, tingling sensation on both hands, both legs, face and both ears- he described the feeling as a "nerve sensation" and his face and both ears felt like they had sunburn. The patient sought medical attention via talking to the pharmacist. No lab diagnostic studies were performed. Treatment given for adverse events included BENADRYL. The patient also reported that the injection site reaction had resolved on an unknown date in September 2015, but not the other symptoms. Relatedness between the events and the therapy with ZOSTAVAX was not reported. Additional information has been requested.